Tom Powles (@tompowles1) 's Twitter Profile
Tom Powles

@tompowles1

Interested in Urology Cancers, biomarkers and drug development.

ID: 1206580727296544769

calendar_today16-12-2019 14:24:22

1,1K Tweet

12,12K Takipçi

62 Takip Edilen

Tom Powles (@tompowles1) 's Twitter Profile Photo
Tom Powles
@tompowles1

4 months ago

NIAGRA: neoadjuvant gem/cis +/- perioperative durvalumab shows significant OS and EFS. #GU25 Matt Galsky now shows the prognostic relevance of pCR. It also showed the durvalumab outperforms the control arm irrespective of pCR. OncoAlert

NIAGRA: neoadjuvant gem/cis +/- perioperative durvalumab shows significant OS and EFS. #GU25 <a href="/MattGalsky/">Matt Galsky</a> now shows the prognostic relevance of pCR. It also showed the durvalumab outperforms the control arm irrespective of pCR. <a href="/OncoAlert/">OncoAlert</a>